China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Stavros Papadopoulos, founder and CEO of TileDB, spoke with Pharmaceutical Executive about how modern databases are struggling to handle life sciences data, which in turn limits scientific discovery.

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Singular Genomics Systems, Inc. (market cap: $50.32M), a company specializing in laboratory analytical instruments, has voluntarily amended its proxy statement following two lawsuits alleging ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively.

Following an international search, Professor Cristóbal Uauy has been appointed as the next Director of the John Innes Centre.